Sedative Effect and Safety of Remimazolam Besylate in ARDS Patients

Clinical trial NCT05758597 · UNKNOWN

Trial details

NCT number: NCT05758597
Sponsor: Zhiming Jiang
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Respiratory Distress Syndrome

Start date: 2024-01-02
Primary completion: 2025-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.